Atlas Trials

Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma

Clinical trial NCT05422521 · COMPLETED

Trial details

NCT number
NCT05422521
Sponsor
Centre Hospitalier Universitaire de Nice
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Refractory or Relapsed Non-Hodgkin's Lymphoma
Start date
2022-08-29
Primary completion
2025-12-10
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.